Drug
Placebo Ophthalmic Solution (Vehicle)
Placebo Ophthalmic Solution (Vehicle) is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph early_phase_1
1
33%
Ph phase_2
2
67%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Recruiting1
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
recruiting133%
not_yet_recruiting133%
terminated133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingearly_phase_1
JN002 for the Treatment of Dry Eye Disease
NCT07245017
not_yet_recruitingphase_2
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958
terminatedphase_2
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922
Clinical Trials (3)
Showing 3 of 3 trials
NCT07245017Early Phase 1
JN002 for the Treatment of Dry Eye Disease
NCT07068958Phase 2
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT05992922Phase 2
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3